반응식
[Cl:1][C:2]1[CH:10]=[C:9]2[C:5]([C:6]([C:12]3[N:13]=[C:14]4[C:20]([C:21](O)=[O:22])=[CH:19][N:18]([CH2:24][O:25][CH2:26][CH2:27][Si:28]([CH3:31])([CH3:30])[CH3:29])[C:15]4=[N:16][CH:17]=3)=[N:7][N:8]2[CH3:11])=[CH:4][CH:3]=1.F[P-](F)(F)(F)(F)F.N1(OC(N(C)C)=[N+](C)C)C2N=CC=CC=2N=N1.S(O)(O)(=O)=O.[NH2:61][C:62]1[NH:63][CH:64]=[CH:65][N:66]=1.C(N(C(C)C)CC)(C)C>O.CN(C)C=O>[NH:63]1[CH:64]=[CH:65][N:66]=[C:62]1[NH:61][C:21]([C:20]1[C:14]2[C:15](=[N:16][CH:17]=[C:12]([C:6]3[C:5]4[C:9](=[CH:10][C:2]([Cl:1])=[CH:3][CH:4]=4)[N:8]([CH3:11])[N:7]=3)[N:13]=2)[N:18]([CH2:24][O:25][CH2:26][CH2:27][Si:28]([CH3:31])([CH3:30])[CH3:29])[CH:19]=1)=[O:22]참가 물질
반응물 4
생성물 1
시약·촉매·용매 2
반응 조건
- 온도
- 70 °C
실험 절차
A solution of 2-(6-chloro-1-methyl-1H-indazol-3-yl)-5-(2-trimethylsilanylethoxymethyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid (205 mg, 0.447 mmol), 1 mL of N,N-dimethylformamide and O-(7-azabenzotriazole-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (208 mg, 0.548 mmol) was stirred 10 min. To the solution was added freshly ground 2-aminoimidazole sulfate (62 mg, 0.468 mmol) and diisopropylethylamine (0.39 mL, 2.2 mmol). The flask was heated to 70° C. and the cloudy yellow solution was stirred 18.5 h, during which time a white precipitate formed. The mixture was allowed to cool, then treated with 20 mL of water. The precipitate was isolated by Buchner filtration, rinsing well with water and dried by air then in vacuo to afford 177 mg of impure 2-(6-chloro-1-methyl-1H-indazol-3-yl)-5-(2-trimethylsilanyl-ethoxymethyl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid (1H-imidazol-2-yl)-amide as a pale yellow solid. MS: (M+H)+=523.
후처리
- customformed
- temperatureto cool
- customThe precipitate was isolated by Buchner filtration
- washrinsing well with water
- customdried by air
출처 및 근거
- ORD 기록
- ord-2a53dce436c84b478158f6d203aa44e1
- 출처 데이터셋
- uspto-grants-2014_02
- 특허 번호
- US08658646B2
연결된 노트
불러오는 중…